Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors.
验证人工智能驱动的外显子组/转录组液体活检平台在实体瘤早期检测、微小残留病灶检测、疾病监测和治疗选择中的应用
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-08986-0
Abraham J, Domenyuk V, Perdigones N, Klimov S, Antani S, Yoshino T, Heath E I, Lou E, Liu S V, Marshall J L, El-Deiry W S, Shields A F, Dietrich M F, Nakamura Y, Fujisawa T, Demetri G D, Barker A, Xiu J, Sacchetti D A, Stahl S, Hahn-Lowry R, Stark A, Swensen J, Poste G, Halbert D D, Oberley M, Radovich M, Sledge G W, Spetzler David B
